Journal
Frontiers in Cell and Deveopmental Biology
Publication Date
1-1-2020
Volume
8
First Page
249
Document Type
Open Access Publication
DOI
10.3389/fcell.2020.00249
Rights and Permissions
Yoest JM, Shirai CL and Duncavage EJ (2020) Sequencing-Based Measurable Residual Disease Testing in Acute Myeloid Leukemia. Front. Cell Dev. Biol. 8:249. doi: 10.3389/fcell.2020.00249 © 2020 Yoest, Shirai and Duncavage. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Yoest, Jennifer M; Shirai, Cara Lunn; and Duncavage, Eric J, "Sequencing-based measurable residual disease testing in acute myeloid leukemia." Frontiers in Cell and Deveopmental Biology. 8, 249 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/9142
